Valsartan Blood Pressure Drug Recall Widens
Dec. 7, 2018 — Drugmaker Mylan Pharmaceuticals this week introduced it has expanded its earlier recall of valsartan-based blood force drugs to incorporate all present plenty of the drug that experience now not expired.
The growth contains an extra 104 rather a lot:
26 plenty of Amlodipine and Valsartan Tablets, in five mg/160 mg, 10 mg/160 mg, five mg/320 mg, and 10 mg/320 mg strengths.
51 plenty of Valsartan Tablets in 40 mg, 80 mg, 160 mg, and 320 mg strengths.
27 plenty of Valsartan and Hydrochlorothiazide Tablets, USP (80 mg/12.five mg, 160 mg/12.five mg, 160 mg/25 mg, 320 mg/12.five mg and 320 mg/25 mg strengths).
The medication have been recalled on account of hint quantities of an impurity, N-nitrosodiethylamine, or NDEA, which might motive most cancers in people, in step with the International Agency for Research on Cancer.
You can discover a complete record of all recalled valsartan merchandise right here.